Measurement of incorporation in family members of patients with benign thyroid diseases after radioiodine therapy;Inkorporationsmessungen bei Angehorigen Von radioiodtherapiepatienten nach Therapie benigner Erkrankungen der Schilddruse

NuklearMedizin

Volumn 37, Issue 3, 1998, Pages 120-123

  Lassmann M ^a   Hanscheid H ^a   Schelper, L F ^a   Korber C ^a   Reiners, C ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

I 131; Incorporation monitoring; Radioiodine exhalation; Radioiodine therapy; Thyroid dose; Thyroid probe

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FAMILY; HUMAN; RADIATION EXPOSURE; RADIATION MONITORING; RADIOISOTOPE THERAPY; RELATIVE; THYROID DISEASE; WHOLE BODY COUNTER; ADOLESCENT; CHILD; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; INDOOR AIR POLLUTION; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TIME;

ADOLESCENT; ADULT; AGED; AIR POLLUTION, INDOOR; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FAMILY; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; RADIATION MONITORING; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; TIME FACTORS;

EID: 0032066280     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632336     Document Type: Article

References (16)

1. Barrington SG, Kettle AG, Mountford PJ et al Radiation exposure of patients' children at home post 1-131 administration. European Journal of Nuclear Medicine 1995; 22: 798.
2. Barrington SF, Kettle AG, Mountford PJ et al. Radiation Exposure of critical groups after 1-131 for thyrotoxicosis. European Journal of Nuclear Medicine 1997; 24: 947.
3. Bundesministerium fur Umweltschutz, Naturschutz und Raktorsicherheit. Entlassung von Patienten. Brief vom 4.11.1997.
4. DIN 25482, Nachweisgrenze und Erkennungsgrenze bei Kernstrahlungsmessungen. Berlin. Beuth Verlag 1992.
5. Eschner W, Hillger HW, Wellner U et al. Radiation Exposure from Inhalation of Iodine Exhaled by Radioiodine Therapy Patients. European Journal of Nuclear Medicine 1997; 24: 948.
6. Greaves CD, Tindale WB, Flynn PJ. A survey of close contact regimes between patients undergoing diagnostic radioisotope procedures and children. Nuclear Medicine Communications 1996; 17: 554-61.
7. International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. In: Annals of the ICRP. H.Smith (ed.). Oxford: Pergamon Press 1988; 53.
8. International Commission on Radiological Protection. Age-dependent Doses to Members of the Public from Intake of Radionuclides: Part 2 Ingestion Dose Coefficients, In: Anuals of the ICRP, Smith H (ed.). Oxford: Pergamon Press 1994, 67.
9. International Commission on Radiological Protection. Age-dependent Doses to Members of the Public from Intake of Radionuclides: Part 4 Inhalation Dose Coefficients. In: Anuals of the ICRP. Smith H (ed.). Oxford: Pergamon Press 1995: 71.
10. Laßmann M, Hänscheid H. Alt P et al. Messung der J-131-Aktivität in der Fortluft einer Radiojodtherapiestation. In: Strahlenschutz: Physik und Meßtechnik Koelzer W, Maushart R (eds.). Köln: TUV Rheinland 1994;719-22.
11. 131 I durch Dritte nach Entlassung von Patienten aus Radioiodtherapiestationen. Nuklearmedizin 1997; 36: A 36.
12. Laßmann M, Hanscheid H, Reiners Chr. Exposition due to Treatment of Thyroid Carcinoma Patients with I-131. In: Medizinische Physik 1995 Richter J (ed.). Wurzburg: Deutsche Gesellschaft für Medizinische Physik. 1995;326-7.
13. Mathieu I, Caussin J, Smeesters P et al. Doses in Family Members after I-131 Treatment. The Lancet 1997; 350. 1074-5.
14. Nishizawa K, Ohara K, Ohshima M et al. Monitoring of Excretions and used materials of patients treated with I-131. Health Physics 1980; 38: 467-81.
15. Strahlenschutzkommission. Strahlenschutzgrundsätze für die Radiojodtherapie. Bundesanzeiger vom 5./6. Dez. 1996; 68: 4769.
16. Zanzonico PB. Radiation Dose to Patients and Relatives Incident to I-131 Therapy, Thyroid 1997: 7; 199-204.